Source:http://linkedlifedata.com/resource/pubmed/id/18313801
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-2-23
|
pubmed:abstractText |
A series of luteolin derivatives 2-20 were prepared, 3-20 of which were first reported. The chemical structures of these compounds were confirmed by means of 1H NMR, ESI-MS and elemental analyses. The compounds were assayed for antibacterial (Bacillus subtilis, Staphylococcus aureus, Pseudomonas fluorescens and Escherichia coli) activities by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl trtrazolium bromide) method. Among the compounds tested, most of them displayed significant activity against the tested strains, and 2-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)-5-hydroxy-7-(2-(3-morpholinopropylamino)ethoxy)-4H-chromen-4-one (17) showed the most favorable antibacterial activity in vitro with MICs of 1.562, 3.125, 3.125, and 6.25 microg/mL against B. subtilis, S. aureus, P. fluorescens and E. coli, respectively. Structure-activity relationships (SAR) were also discussed based on the obtained experimental data.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
1768-3254
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
908-14
|
pubmed:meshHeading |
pubmed-meshheading:18313801-Anti-Bacterial Agents,
pubmed-meshheading:18313801-Bacillus subtilis,
pubmed-meshheading:18313801-Escherichia coli,
pubmed-meshheading:18313801-Luteolin,
pubmed-meshheading:18313801-Microbial Sensitivity Tests,
pubmed-meshheading:18313801-Pseudomonas fluorescens,
pubmed-meshheading:18313801-Spectrum Analysis,
pubmed-meshheading:18313801-Staphylococcus aureus,
pubmed-meshheading:18313801-Structure-Activity Relationship
|
pubmed:year |
2009
|
pubmed:articleTitle |
Synthesis and biological evaluation of novel luteolin derivatives as antibacterial agents.
|
pubmed:affiliation |
Institute of Functional Biomolecules, State Key Laboratory of Pharmaceutical Biotechnology, Nanjing University, Nanjing 210093, People's Republic of China.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|